Projet EDICT (Horizon Europe, appel à projets 2024)
Action : Doctoral Networks
Panel : Life Sciences
Statut du projet : SIGNED

“Advancing Equity, Diversity, and Inclusion in Clinical Trials” (EDICT) establishes an innovative Doctoral Network to transform how equity, diversity, and inclusion (EDI) principles are embedded in clinical trials across Europe. While clinical trials are essential for advancing medical knowledge, systematic exclusion of diverse populations undermines scientific validity and limits healthcare impact. EDICT will train the next generation of research leaders, equipped with specialised methodological expertise and practical skills to transform how clinical trials are designed and conducted, ensuring meaningful representation of diverse populations.  Leveraging expertise from multiple sectors—including academia, the pharmaceutical and MedTech industries, patient advocacy, regulatory bodies, trial networks, science communication, and evidence production—EDICT will support 16 (14 EU; 2 Swiss) doctoral candidates in developing solutions that enhance recruitment, improve data inclusivity, and ensure that trial outcomes are representative of broader population needs. The network will deliver concrete EDI innovations, including standardised metrics for measuring trial diversity, AI-powered tools for detecting recruitment bias, culturally-adapted consent processes, and implementation frameworks. These outputs will transform how EDI is implemented across the clinical trials ecosystem.  Through structured mobility between interdisciplinary academic, industry and policy environments, doctoral candidates will develop comprehensive expertise across four key domains: standardised measurement of trial diversity, innovative EDI methodologies, practical implementation tools, and frameworks for systemic change. EDICT will establish a permanent network of EDI champions, driving sustainable improvement in clinical trial inclusivity while advancing Europe's capacity to conduct equitable, representative, and scientifically robust health research.

Mots clés : clinical trials methodology trials methodology equity diversity inclusion edi dei patient engagement inclusive trial design

Participants :
- Ecrin european clinical research infrastructure network (France) — Partner, associated partner, Recherche, subvention : 0.0 €
- Roche (Switzerland) (Suisse) — Partner, associated partner, Autres, subvention : 0.0 €
- Hospital Universitario La Paz (Espagne) — Partner, beneficiary, Autres, subvention : 564376.32 €
- Madrid Health Service (Espagne) — Partner, associated partner, Organismes publics (hors enseignement & recherche), subvention : 0.0 €
- Université d'Uppsala (Suède) — Partner, associated partner, Enseignement supérieur ou secondaire, subvention : 0.0 €
- Université de Split (Croatie) — Partner, associated partner, Enseignement supérieur ou secondaire, subvention : 0.0 €
- Pfizer (United States) (Etats-Unis) — Partner, associated partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Medtronic (United States) (Etats-Unis) — Partner, associated partner, Organismes privés (hors enseignement), subvention : 0.0 €
- The synergist (Belgique) — Partner, associated partner, Autres, subvention : 0.0 €
- Université de Bâle (Suisse) — Partner, associated partner, Enseignement supérieur ou secondaire, subvention : 0.0 €
- Université nationale d'Irlande à Galway (Irlande) — Coordinator, beneficiary, Enseignement supérieur ou secondaire, subvention : 1023261.12 €
- Wcn (Pays-Bas) — Partner, associated partner, Recherche, subvention : 0.0 €
- Sense about Science (Royaume-Uni) — Partner, associated partner, Autres, subvention : 0.0 €
- Université d'Ottawa (Canada) — Partner, associated partner, Enseignement supérieur ou secondaire, subvention : 0.0 €
- Julius clinical research bv (Pays-Bas) — Partner, associated partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Université Paris Cité (France) — Partner, beneficiary, Enseignement supérieur ou secondaire, subvention : 629338.32 €
- Medicines Evaluation Board (Pays-Bas) — Partner, associated partner, Organismes publics (hors enseignement & recherche), subvention : 0.0 €
- Université d'Utrecht (Pays-Bas) — Partner, associated partner, Enseignement supérieur ou secondaire, subvention : 0.0 €
- University Medical Center Utrecht (Pays-Bas) — Partner, beneficiary, Enseignement supérieur ou secondaire, subvention : 915857.28 €
- Université d'Aarhus (Danemark) — Partner, associated partner, Enseignement supérieur ou secondaire, subvention : 0.0 €
- Université d'Aberdeen (Royaume-Uni) — Partner, beneficiary, Enseignement supérieur ou secondaire, subvention : 697476.24 €
- Université de Liverpool (Royaume-Uni) — Partner, associated partner, Enseignement supérieur ou secondaire, subvention : 0.0 €
- Bruyere research institute (Canada) — Partner, associated partner, Autres, subvention : 0.0 €
- Medtronic (United Kingdom) (Royaume-Uni) — Partner, associated partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Université autonome de Madrid (Espagne) — Partner, associated partner, Enseignement supérieur ou secondaire, subvention : 0.0 €
- Université catholique croate (Croatie) — Partner, beneficiary, Enseignement supérieur ou secondaire, subvention : 519624.72 €